NASDAQ:GPCR | Profit Breakdown | Structure Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$118.63M-$105.93M-$106.16M
2026-03-31-$89.38M-$75.78M-$75.97M
2025-12-31$23.99M$33.17M$33M
2025-09-30-$73.79M-$65.6M-$65.71M
2025-06-30-$70.45M-$61.52M-$61.66M
2025-03-31-$56.31M-$46.74M-$46.83M
2024-12-31-$47.06M-$36.34M-$36.48M
2024-09-30-$45.84M-$33.89M-$33.98M
2024-06-30-$33.32M-$25.98M-$26.03M
2024-03-31-$32.02M-$26.01M-$26.04M
2023-12-31-$30.99M-$24.82M-$24.5M
2023-09-30-$26.15M-$23.46M-$23.86M
2023-06-30-$25.99M-$23.16M-$23.28M
2023-03-31-$19.65M-$17.95M-$17.98M
2022-12-31-$12.96M-$12.06M-$11.88M
2022-09-30-$12.69M-$12.34M-$12.42M
2022-06-30-$13.96M-$13.88M-$13.95M
2022-03-31-$12.95M-$13.02M-$13.08M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$176.56M-$140.69M-$141.2M
2024-12-31-$158.23M-$122.22M-$122.53M
2023-12-31-$102.78M-$89.38M-$89.62M
2022-12-31-$52.56M-$51.3M-$51.32M